CN109371008A - A kind of nucleic acid extraction amplification detection kit and its detection method - Google Patents
A kind of nucleic acid extraction amplification detection kit and its detection method Download PDFInfo
- Publication number
- CN109371008A CN109371008A CN201811247122.5A CN201811247122A CN109371008A CN 109371008 A CN109371008 A CN 109371008A CN 201811247122 A CN201811247122 A CN 201811247122A CN 109371008 A CN109371008 A CN 109371008A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- pcr
- detection kit
- drying
- acid extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention proposes a kind of nucleic acid extraction amplification detection kit, which is made of cracking liquid kit and PCR pipe.Nucleic acid cleavage liquid is held in cracking liquid kit, sample to be tested is added after nucleic acid cleavage liquid, viral nucleic acid is released by the effect of the nucleic acid cleavage liquid, and realizes purifying, gains can be added directly into PCR pipe realization PCR detection after nucleic acid cleavage liquid is added in sample.The freezing dry powder PCR amplification system reagent for being directly used in quantitative fluorescent PCR measurement is placed in the PCR pipe, the freezing dry powder PCR amplification system reagent is the gains prepared as raw material by freeze drying process using PCR reaction buffer, archaeal dna polymerase, atopic primer, probe and freeze drying protectant.
Description
Technical field
The present invention relates to technical field of biological more particularly to a kind of nucleic acid extraction amplification detection kit and its detections
Method.
Background technique
Real-Time Fluorescent Quantitative PCR Technique is widely used to hereditary disease molecular diagnosis, clinical examination, animals and plants inlet and outlet inspection
The various fields such as epidemic disease, food safety monitoring, edaphon detection and paternity test.Due in blood, food, soil equal samples
Containing a large amount of inhibiting factors, such as hemoglobin, protoferriheme, lactoferrin, humic acid, to conventional Taq archaeal dna polymerase
Apparent inhibiting effect will be generated.Therefore, it is necessary to be subsequently used for PCR amplification first from these sample to be tested separation and Extraction nucleic acid.Core
It is one of key method in the detection of nucleic acids first step and molecular biology that acid, which extracts,.Basis is provided for downstream nucleic acid detection, is mentioned
Quality and integrality is taken to directly affect clinical research or diagnosis.
General nucleic acid extraction process includes two steps: the cracking and purifying of sample.Traditional extraction reagent is due to acquirement rate phase
To lower, and step is more many and diverse, to extracting work belt centainly to influence, it is difficult to obtain qualified nucleic acid samples.Paramagnetic particle method is close
The nucleic acid extraction mode to grow up for several years, the nucleic acid purity of extraction is high, yield is big.Obviously, operated in accordance with conventional methods step it is more, at
It is this height, larger to the requirement of sample and easily cause cross contamination, it is unfavorable for client's rapidly extracting purification of nucleic acid sample.
In addition, reagent is not mostly instant in the most widely used real-time fluorescence PCR technology of current detection of nucleic acids
, it causes PCR to detect the problems such as generally existing complicated for operation, bothersome, required cost is high, complicated configuration work is needed before use
Make, be easy to cause the error even failure of test.Different personnel's operations also cause experimental error；Certain reagents save at normal temperature
It is unstable；It cannot accomplish one-step method rapidly extracting nucleic acid；PCR detection reagent needs on-site manual to configure, and multiple steps need people
The detecting instrument of work label, each stage is independent, is unfavorable for full automatic treatment a large number of experiments sample.
Summary of the invention
In view of above-mentioned disadvantages described above existing in the prior art, the invention proposes a kind of nucleic acid extraction augmentation detection reagents
Box and its detection method.The nucleic acid extraction amplification detection kit and its detection method, which use, directly extracts simultaneously amplified reaction inspection
Survey clinical sample in viral nucleic acid real-time fluorescence PCR reaction system, by sample to be tested be added lysate realize nucleic acid cleavage with
Purifying, the product for cracking after purification can directly carry out PCR detection, and with the freeze-dried powder reagent of instant realize amplified reaction with
PCR detection, without preparing before surveying, it is that template carries out this bottle of PCR amplification that detection, which is thoroughly solved dependent on the nucleic acid DNA of purifying,
Neck problem, applicable sample include blood, serum, blood plasma, saliva, urine, tissue fluid, sperm, juice, pus and breathing liquid and
The polymorphic types sample such as mucus.
The present invention provides a kind of nucleic acid extraction amplification detection kit characterized by comprising cracking liquid kit and
PCR pipe cracks in liquid kit and holds nucleic acid cleavage liquid, releases viral nucleic acid by the effect of the nucleic acid cleavage liquid
Come；The freezing dry powder PCR amplification system reagent for being directly used in quantitative fluorescent PCR measurement is placed in the PCR pipe, the freezing is dry
Powder PCR amplification system reagent is with PCR reaction buffer, archaeal dna polymerase, atopic primer, probe and frozen-dried protective
Agent is the gains that raw material is prepared by freeze drying process.
Wherein, the nucleic acid cleavage liquid include CuHCl, NaOH, ethylenediamine tetra-acetic acid, trishydroxymethylaminomethane, NaCl,
Triton X-100, surfactant, phenol, isoamyl alcohol.Wherein, the concentration of CuHCl is 5.6-5.85g/10ML；Second
Ethylenediamine tetraacetic acid (EDTA) 0.03-0.04g/10ML；Trishydroxymethylaminomethane 0.06-0.07g/10ML；NaCl 0.01-0.015g/
10ML；Triton X-100 2%-10%(volume ratio)；Surfactant 0.075-0.1%(volume ratio)；Nucleic acid cleavage
1%-2.5%(volume ratio is added in liquid) phenol, isoamyl alcohol mixed liquor, wherein phenol, isoamyl alcohol volume ratio 20:1-25:1.
The surfactant using it is following any one: lauryl sodium sulfate, hexadecyl first triamine, poly- second
Alkene pyrrolidone, lauroyl propylhomoserin sodium.
Wherein, the freezing dry powder PCR amplification system reagent is prepared in the following way: by PCR reaction buffer, DNA
After polymerase, atopic primer, probe are mixed with frozen-dried protective agent solution according to predetermined ratio, freeze-drying.
Wherein, the freeze-drying is divided into precooling, main freeze-drying, reinforces dry three phases, and the first stage is
Precooling, slow cooling is to -35 to -40 degrees Celsius, and cooling duration is greater than 1 hour, and holding 2.5 is small under the conditions of the temperature
When；Second stage is the main freeze-drying stage, and temperature is kept for -15 to -20 degrees Celsius, is kept for 5 hours, wherein air pressure is maintained at
0.1mbar；Phase III is to reinforce drying, and temperature is kept for 15-25 degrees Celsius, and drying time 2 hours, air pressure kept 0.1mbar.
Wherein, preparing the freeze drying protectant that the freezing dry powder PCR amplification system reagent uses includes: mannitol, poly- second
Glycol, maltose, ascorbic acid and polyvinylpyrrolidone.Wherein, mannitol additional amount 3-5g/10ML；Polyethylene glycol adds
Enter amount 2.5-3g/10ML；Maltose additional amount 15-18g/10ML；Ascorbic acid additional amount 0.4-0.6g/10ML；Polyethylene pyrrole
Pyrrolidone 0.8-1.5g/ML.
Wherein, the frozen-dried protective agent solution is prepared with the deionized water that pyrophosphatase is added.Wherein, disulfurase plus
Entering amount is 1.1-1.6g/10ML.
Wherein, preparing the PCR reaction buffer that the freezing dry powder PCR amplification system reagent uses includes: deoxyribose
Ribonucleoside triphosphote, magnesium chloride.
It wherein, also include transient metal sulfide in the freezing dry powder PCR amplification system reagent.
The present invention and then the claimed method for carrying out detection of nucleic acids using the above nucleic acid extraction amplification detection kit.
Invention enhances nucleic acid cleavage effectiveness and degree of purification, precipitate without nucleic acid, and lysate can be detected directly,
Realize that amplified reaction and PCR detect with the freeze-dried powder reagent of instant, without preparing before surveying, detection is thoroughly solved dependent on pure
The nucleic acid DNA of change is the bottleneck that template carries out PCR amplification problem, and applicable sample includes blood, serum, blood plasma, saliva, urine
Liquid, tissue fluid, sperm, juice, pus and the breathing polymorphic types sample such as liquid and mucus.
Specific embodiment
Below by embodiment, technical solution of the present invention is described in further detail.
The present invention provides a kind of nucleic acid extraction amplification detection kit, and the nucleic acid extraction amplification detection kit is by lysate
Kit and PCR pipe composition.Nucleic acid cleavage liquid is held in cracking liquid kit, sample to be tested is added after nucleic acid cleavage liquid,
Viral nucleic acid is released by the effect of the nucleic acid cleavage liquid, and realizes purifying, sample is added after nucleic acid cleavage liquid
Gains can be added directly into PCR pipe and realize PCR detection.It is placed in the PCR pipe and is directly used in quantitative fluorescent PCR measurement
Freezing dry powder PCR amplification system reagent, the freezing dry powder PCR amplification system reagent are polymerize with PCR reaction buffer, DNA
Enzyme, atopic primer, probe and freeze drying protectant are the gains that raw material is prepared by freeze drying process.
(1) nucleic acid cleavage liquid
Specifically, the nucleic acid cleavage liquid includes CuHCl, ethylenediamine tetra-acetic acid, trishydroxymethylaminomethane, NaCl, poly- second
Glycol octyl phenyl ether, surfactant, phenol, isoamyl alcohol.Wherein, the concentration of CuHCl is 5.6-5.85g/10ML, preferably
5.75g/10ML.Ethylenediamine tetra-acetic acid 0.03-0.04g/10ML, preferably 0.038g/10ML.Trishydroxymethylaminomethane 0.06-
0.07g/10ML, preferably 0.062g/10ML.NaCl 0.01-0.015g/10ML, preferably 0.011g/10ML.Polyethylene glycol is pungent
Base phenyl ether 2%-10%(volume ratio), preferably 2.7%.Surfactant can be using any one or more following mixing:
Lauryl sodium sulfate, hexadecyl first triamine, polyvinylpyrrolidone, lauroyl propylhomoserin sodium；Surfactant
0.075-0.1%(volume ratio), preferably 0.85%.1%-2.5%(volume ratio is added in nucleic acid cleavage liquid) phenol, isoamyl alcohol it is mixed
Liquid is closed, wherein phenol, isoamyl alcohol volume ratio 20:1-25:1.Lysate pH value is 4-4.5.It is produced obtained by nucleic acid cleavage to realize
The subsequent Direct PCR detection of object, lysate of the invention can produce the nucleic acid product of high-purity and high integrality, will be in cell
The ingredients such as protein, polysaccharide remove completely, and reagent noresidue, unstressed configuration depression effect, retain nucleic acid molecules base itself
The integrality of sequence.The present invention realizes in cracking process that CuHCl and NaCl mixed solution provide the ring for promoting nucleic acid cleavage release
Border, the effect for protecting nucleic acid not degraded by nuclease are prominent；Surfactant and protein, polysaccharide form slightly solubility sediment,
Realize the separation of impurity and nucleic acid；Phenol, isoamyl alcohol further promote the separation of protein and nucleic acid compositions, and wherein phenol makes egg
The denaturation of white matter ingredient, the protein of denaturation is retained in organic phase, and nucleic acid is left water phase, and isoamyl alcohol promotes organic phase and water
Mutually separate；Lysate is without nucleic acid precipitate components such as ethyl alcohol, isopropanols, therefore nucleic acid compositions are maintained in lysate, Ke Yizhi
Tap into row PCR detection.Wherein, CuHCl, NaCl, surfactant, phenol, the concentration of isoamyl alcohol and lysate pH value all bases
It is optimized in experiment, to realize the maximization of nucleic acid extraction yield.
The lysate embodiment 1-3 and its experiment effect that lower mask body introduction is realized according to the present invention.
Embodiment 1:
Scheme according to the invention prepares nucleic acid cleavage liquid 40ML, including CuHCl 5.6g/10ML, ethylenediamine tetra-acetic acid
0.03g/10ML, trishydroxymethylaminomethane 0.06g/10ML, NaCl 0.01g/10ML, Triton X-100 2%(body
Product ratio), surfactant can use lauryl sodium sulfate, surfactant 0.075%(volume ratio), 1%(volume ratio
Example) phenol, isoamyl alcohol mixed liquor, wherein phenol, isoamyl alcohol volume ratio 20:1, adjusting lysate pH value is 4.
Embodiment 2
Scheme according to the invention prepares nucleic acid cleavage liquid 40ML, including CuHCl 5.85g/10ML, ethylenediamine tetra-acetic acid
0.04g/10ML, trishydroxymethylaminomethane 0.07g/10ML, NaCl 0.015g/10ML, Triton X-100 10%
(volume ratio), surfactant can be mixed using polyvinylpyrrolidone, lauroyl propylhomoserin sodium, surfactant 0.1%
(volume ratio), 2.5%(volume ratio) phenol, isoamyl alcohol mixed liquor, wherein phenol, isoamyl alcohol volume ratio 25:1 adjust cracking
Liquid pH value is 4.5.
Embodiment 3
Scheme according to the invention prepares nucleic acid cleavage liquid 40ML, including CuHCl 5.75g/10ML, ethylenediamine tetra-acetic acid
0.038g/10ML, trishydroxymethylaminomethane 0.062g/10ML, NaCl 0.011g/10ML, Triton X-100 are
2.7%(volume ratio), surfactant uses hexadecyl first triamine, surfactant 0.85%(volume ratio), nucleic acid is split
Solve liquid in be added 2.5%(volume ratio) phenol, isoamyl alcohol mixed liquor, wherein phenol, isoamyl alcohol volume ratio 22:1, adjusting are split
Solving liquid pH value is 4.
Take each 0.5ML of the nucleic acid cleavage liquid of above three embodiments, and take viral plasma sample 0.1ML, by sample with split
Solution liquid is mixed to centrifuge tube, and centrifuge tube is reversed 3-5 times, and nucleic acid is made to realize sufficiently cracking release.It is micro- using NanoDrop 1000
The nucleic acid extractive yield measured after nucleic acid analyzer measurement is sufficiently reacted in lysate is as follows: embodiment 1 is 12.3 μ g, embodiment
2 be 11.7 μ g, and embodiment 3 is 14.8 μ g, it is seen that nucleic acid cleavage output effect is good, and lysate nucleic acid concentration can be used for PCR
Directly measure.
(2) freezing dry powder PCR amplification system
The freezing dry powder PCR amplification system reagent for being directly used in quantitative fluorescent PCR measurement is placed in the PCR pipe, it will be to test sample
This addition lysate and sufficiently crack after resulting liquid product and go RNA water be directly added into the PCR pipe realize amplification and PCR
Fluorometric investigation.The freezing dry powder PCR amplification system reagent is prepared in the following way: PCR reaction buffer, DNA are polymerize
After enzyme, atopic primer, probe are mixed with frozen-dried protective agent solution according to predetermined ratio, three phases are divided to carry out freezing dry
It is dry.Wherein, the first stage is precooling, and slow cooling is to -35 to -40 degrees Celsius, and cooling duration is greater than 1 hour, and in the temperature
It is kept for 2.5 hours under the conditions of degree；Second stage is the freeze-drying stage, and temperature is kept for -15 to -20 degrees Celsius, is kept for 5 hours,
Wherein air pressure is maintained at 0.1mbar；Phase III is to reinforce drying, 15-25 degrees Celsius of temperature holding, drying time 2 hours, gas
Pressure keeps 0.1mbar.Wherein, the effect of freeze drying protectant is the activity of enzyme needed for keeping PCR to react in freeze-drying process, preparation
The freeze drying protectant that the freezing dry powder PCR amplification system reagent uses includes: mannitol, polyethylene glycol, maltose, Vitamin C
Acid and polyvinylpyrrolidone；It is molten as the freeze drying protectant that deionized water pyrophosphatase is added prepares mentioned component
Liquid.Wherein, mannitol additional amount 3-5g/10ML；Polyethylene glycol additional amount 2.5-3g/10ML；Maltose additional amount 15-18g/
10ML, preferably 16.4g/10ML；Ascorbic acid additional amount 0.4-0.6g/10ML；Polyvinylpyrrolidone 0.8-1.5g/ML.It is burnt
The additional amount of sulfatase is 1.1-1.6g/10ML.Mannitol and polyethylene glycol mixing are used as excipient to have good effect, protect
The viscosity for holding freezing dry powder, avoids surface porosity.Maltose, ascorbic acid and polyvinylpyrrolidone are protected as mixed type
Agent can substitute the water and protein composition hydrogen bond of loss in freeze-drying process, play a protective role, keep protein active.
Wherein, preferably, it prepares in the reagent of the freezing dry powder PCR amplification system also comprising transient metal sulfide
MoS2, additional amount are 55 μ g/10ML, can promote the sensitivity and specificity of detection.Also, prepare the freezing dry powder PCR
The PCR reaction buffer that amplification system reagent uses includes: deoxyribonucleoside triphosphate, magnesium chloride, is conducive to amplification effect
The realization of fruit.
The freezing dry powder PCR amplification system reagent 1-3 and its experiment effect that lower mask body introduction is realized according to the present invention.
Embodiment 1
Frozen-dried protective agent solution 10ML is prepared, specific ingredient is as follows: mannitol additional amount 3g/10ML, polyethylene glycol additional amount
2.5g/10ML；Maltose additional amount 15g/10ML, ascorbic acid additional amount 0.4g/10ML, polyvinylpyrrolidone 0.8g/ML,
Disulfurase 1.1g/10ML.By PCR reaction buffer, archaeal dna polymerase, atopic primer, probe and above-mentioned frozen-dried protective
After agent solution is mixed according to predetermined ratio, three phases is divided to be freeze-dried.Wherein, the first stage is precooling, is slowly dropped
To -35 to -40 degrees Celsius, cooling duration is greater than 1 hour temperature, and is kept for 2.5 hours under the conditions of the temperature；Based on second stage
It is freeze-dried the stage, temperature is kept for -15 to -20 degrees Celsius, is kept for 5 hours, wherein air pressure is maintained at 0.1mbar；Third rank
Section is reinforces drying, and temperature is kept for 15-25 degrees Celsius, and drying time 2 hours, air pressure kept 0.1mbar.
Embodiment 2
Frozen-dried protective agent solution 10ML is prepared, specific ingredient is as follows: mannitol additional amount 5g/10ML, polyethylene glycol additional amount 3g/
10ML；Maltose additional amount 18g/10ML, ascorbic acid additional amount 0.6g/10ML, polyvinylpyrrolidone 1.5g/ML, burnt sulphur
Sour enzyme 1.6g/10ML.PCR reaction buffer, the archaeal dna polymerase, reaction spy that deoxyribonucleoside triphosphate, magnesium chloride are mixed
After specific primer, probe are mixed with above-mentioned frozen-dried protective agent solution according to predetermined ratio, three phases is divided to be freeze-dried.Its
In, the first stage is precooling, and slow cooling is to -35 to -40 degrees Celsius, and cooling duration is greater than 1 hour, and in the temperature condition
It is lower to be kept for 2.5 hours；Second stage is the freeze-drying stage, and temperature is kept for -15 to -20 degrees Celsius, is kept for 5 hours, wherein gas
Pressure is maintained at 0.1mbar；Phase III is to reinforce drying, and temperature is kept for 15-25 degrees Celsius, and drying time 2 hours, air pressure was kept
0.1mbar。
Embodiment 3
Frozen-dried protective agent solution 10ML is prepared, specific ingredient is as follows: mannitol additional amount 4.5g/10ML, polyethylene glycol additional amount
2.8g/10ML；Maltose additional amount 16.5g/10ML, ascorbic acid additional amount 0.55g/10ML, polyvinylpyrrolidone 1.1g/
ML, disulfurase 1.35g/10ML.By PCR reaction buffer, archaeal dna polymerase, atopic primer, probe and above-mentioned freeze-drying
After protection agent solution is mixed according to predetermined ratio, three phases is divided to be freeze-dried.Wherein, the first stage is precooling, is delayed
Slowly -35 to -40 degrees Celsius are cooled to, cooling duration is greater than 1 hour, and is kept for 2.5 hours under the conditions of the temperature；Second stage
To be freeze-dried the stage, temperature is kept for -15 to -20 degrees Celsius, is kept for 5 hours, wherein air pressure is maintained at 0.1mbar；Third rank
Section is reinforces drying, and temperature is kept for 15-25 degrees Celsius, and drying time 2 hours, air pressure kept 0.1mbar.
Freezing dry powder PCR amplification system reagent prepared by three above embodiment is respectively divided into 5 parts, in 37 degrees Celsius of rings
It is placed under border 0,3,7,10,20 day, is then loaded test agent made from lysate embodiment 1-3, concussion mixes, upper machine after centrifugation
PCR test is carried out, embodiment 1- embodiment 3 is 10 in 0,3,7,10 day measurement sensitivity4, sensitivity in 20 days is 105.It can
Measurement sensitivity can be kept the long period by seeing.
As it can be seen that being precipitated without nucleic acid, lysate can be direct invention enhances nucleic acid cleavage effectiveness and degree of purification
Detection realizes that amplified reaction and PCR detect with the freeze-dried powder reagent of instant, without being prepared before surveying, detection thoroughly solve according to
The nucleic acid DNA of Lai Yu purifying is the bottleneck that template carries out PCR amplification problem, and applicable sample includes blood, serum, blood plasma, saliva
Liquid, urine, tissue fluid, sperm, juice, pus and the breathing polymorphic types sample such as liquid and mucus.
Above embodiments are merely to illustrate the present invention, and not limitation of the present invention, the common skill in relation to technical field
Art personnel can also make a variety of changes and modification without departing from the spirit and scope of the present invention, therefore all etc.
Same technical solution also belongs to scope of the invention, and scope of patent protection of the invention should be defined by the claims.
Claims (10)
1. a kind of nucleic acid extraction amplification detection kit characterized by comprising cracking liquid kit and PCR pipe, lysate
Nucleic acid cleavage liquid is held in kit, releases viral nucleic acid by the effect of the nucleic acid cleavage liquid；In the PCR pipe
Place the freezing dry powder PCR amplification system reagent for being directly used in quantitative fluorescent PCR measurement, the freezing dry powder PCR amplification system
It is raw material by cold that reagent, which is using PCR reaction buffer, archaeal dna polymerase, atopic primer, probe and freeze drying protectant,
The gains of drying process preparation are lyophilized；
Wherein, the nucleic acid cleavage liquid includes CuHCl, NaOH, ethylenediamine tetra-acetic acid, trishydroxymethylaminomethane, NaCl, poly- second
Glycol octyl phenyl ether, surfactant, phenol, isoamyl alcohol；
The freezing dry powder PCR amplification system reagent is prepared in the following way: by PCR reaction buffer, archaeal dna polymerase, anti-
After answering specific primer, probe to mix with frozen-dried protective agent solution according to predetermined ratio, freeze-drying.
2. nucleic acid extraction amplification detection kit according to claim 1, which is characterized in that in the nucleic acid cleavage liquid,
The concentration of CuHCl is 5.6-5.85g/10ML；Ethylenediamine tetra-acetic acid 0.03-0.04g/10ML；Trishydroxymethylaminomethane 0.06-
0.07g/10ML；NaCl 0.01-0.015g/10ML；Triton X-100 2%-10%(volume ratio)；Surface-active
Agent 0.075-0.1%(volume ratio)；In nucleic acid cleavage liquid be added 1%-2.5%(volume ratio) phenol, isoamyl alcohol mixed liquor,
Middle phenol, isoamyl alcohol volume ratio 20:1-25:1.
3. nucleic acid extraction amplification detection kit according to claim 2, which is characterized in that the surfactant uses
Below any one: lauryl sodium sulfate, hexadecyl first triamine, polyvinylpyrrolidone, lauroyl propylhomoserin sodium.
4. nucleic acid extraction amplification detection kit according to claim 1, which is characterized in that the freeze-drying is divided into pre-
Dry three phases are reinforced in freezing, main freeze-drying, and the first stage is precooling, slow cooling to -35 to -40 degrees Celsius,
The duration that cools down is greater than 1 hour, and is kept for 2.5 hours under the conditions of the temperature；Second stage is main freeze-drying stage, temperature
It is kept for -15 to -20 degrees Celsius, is kept for 5 hours, wherein air pressure is maintained at 0.1mbar；Phase III is to reinforce drying, and temperature is protected
15-25 degrees Celsius is held, drying time 2 hours, air pressure kept 0.1mbar.
5. nucleic acid extraction amplification detection kit according to claim 1, which is characterized in that prepare the freezing dry powder
The freeze drying protectant that PCR amplification system reagent uses includes: mannitol, polyethylene glycol, maltose, ascorbic acid and polyethylene
Pyrrolidones.
6. nucleic acid extraction amplification detection kit according to claim 5, which is characterized in that mannitol additional amount 3-5g/
10ML；Polyethylene glycol additional amount 2.5-3g/10ML；Maltose additional amount 15-18g/10ML；Ascorbic acid additional amount 0.4-
0.6g/10ML；Polyvinylpyrrolidone 0.8-1.5g/ML.
7. nucleic acid extraction amplification detection kit according to claim 6, which is characterized in that going for pyrophosphatase is added
Ionized water prepares the frozen-dried protective agent solution.
8. nucleic acid extraction amplification detection kit according to claim 7, which is characterized in that prepare the freezing dry powder
The PCR reaction buffer that PCR amplification system reagent uses includes: deoxyribonucleoside triphosphate, magnesium chloride.
9. nucleic acid extraction amplification detection kit according to claim 8, which is characterized in that the freezing dry powder PCR expands
Increasing also includes transient metal sulfide in system reagent.
10. carrying out detection of nucleic acids using the above nucleic acid extraction amplification detection kit described in any one of claim 1-9
Method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811247122.5A CN109371008B (en) | 2018-10-25 | 2018-10-25 | Nucleic acid extraction amplification detection kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811247122.5A CN109371008B (en) | 2018-10-25 | 2018-10-25 | Nucleic acid extraction amplification detection kit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109371008A true CN109371008A (en) | 2019-02-22 |
| CN109371008B CN109371008B (en) | 2021-03-26 |
Family
ID=65402063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811247122.5A Active CN109371008B (en) | 2018-10-25 | 2018-10-25 | Nucleic acid extraction amplification detection kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109371008B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110016475A (en) * | 2019-05-10 | 2019-07-16 | 宁波艾捷康宁生物科技有限公司 | Faeces DNA extracts kit |
| CN111394346A (en) * | 2020-03-20 | 2020-07-10 | 基蛋生物科技股份有限公司 | Preparation method and application of freeze-dried microspheres of RNA nucleic acid releasing agent and PCR amplification reagent |
| CN111808847A (en) * | 2020-08-12 | 2020-10-23 | 济南国益生物科技有限公司 | Release agent for rapidly extracting nucleic acid by one-step method and preparation and use methods thereof |
| CN112301097A (en) * | 2019-07-26 | 2021-02-02 | 申翌生物科技(杭州)有限公司 | Sample lysis and PCR reaction composition |
| CN114717223A (en) * | 2022-03-29 | 2022-07-08 | 翌圣生物科技(上海)股份有限公司 | Reagent for treating biological sample and its application |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105349529A (en) * | 2015-12-09 | 2016-02-24 | 江苏正大天创生物工程有限公司 | Freeze-drying protective agent applied to nucleic acid amplification system |
| CN107022651A (en) * | 2017-06-02 | 2017-08-08 | 辽宁润基生物科技有限公司 | The kit and its detection method of a kind of quick detection hepatitis C virus nucleic acid |
| CN107828633A (en) * | 2017-12-14 | 2018-03-23 | 苏州天隆生物科技有限公司 | A kind of nucleic acid extraction and reagent device, reagent and the method for detection |
-
2018
- 2018-10-25 CN CN201811247122.5A patent/CN109371008B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105349529A (en) * | 2015-12-09 | 2016-02-24 | 江苏正大天创生物工程有限公司 | Freeze-drying protective agent applied to nucleic acid amplification system |
| CN107022651A (en) * | 2017-06-02 | 2017-08-08 | 辽宁润基生物科技有限公司 | The kit and its detection method of a kind of quick detection hepatitis C virus nucleic acid |
| CN107828633A (en) * | 2017-12-14 | 2018-03-23 | 苏州天隆生物科技有限公司 | A kind of nucleic acid extraction and reagent device, reagent and the method for detection |
Non-Patent Citations (2)
| Title |
|---|
| LIU WANG 等: "Transition Metal Dichalcogenide Nanosheets for Visual Monitoring PCR Rivaling a Real-Time PCR Instrument", 《ACS APPL. MATER. INTERFACES》 * |
| 姚静 等: "《药物冻干制剂技术的设计及应用》", 30 June 2007 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110016475A (en) * | 2019-05-10 | 2019-07-16 | 宁波艾捷康宁生物科技有限公司 | Faeces DNA extracts kit |
| CN112301097A (en) * | 2019-07-26 | 2021-02-02 | 申翌生物科技(杭州)有限公司 | Sample lysis and PCR reaction composition |
| CN112301097B (en) * | 2019-07-26 | 2022-10-21 | 申翌生物科技(杭州)有限公司 | Sample lysis and PCR reaction composition |
| CN111394346A (en) * | 2020-03-20 | 2020-07-10 | 基蛋生物科技股份有限公司 | Preparation method and application of freeze-dried microspheres of RNA nucleic acid releasing agent and PCR amplification reagent |
| CN111808847A (en) * | 2020-08-12 | 2020-10-23 | 济南国益生物科技有限公司 | Release agent for rapidly extracting nucleic acid by one-step method and preparation and use methods thereof |
| CN114717223A (en) * | 2022-03-29 | 2022-07-08 | 翌圣生物科技(上海)股份有限公司 | Reagent for treating biological sample and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109371008B (en) | 2021-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109371008A (en) | A kind of nucleic acid extraction amplification detection kit and its detection method | |
| ES2965345T3 (en) | Nucleic acid release agent, PCR nucleic acid amplification method and PCR amplification kit | |
| CA2428864C (en) | Method and device for collecting and stabilizing a biological sample | |
| EP2900834B1 (en) | Stabilisation of biological samples | |
| JP4607323B2 (en) | Container for collecting blood | |
| US20060147944A1 (en) | Reagents and methods for storage and processing of biological samples for DNA analysis | |
| US20140227687A1 (en) | Stabilisation and isolation of extracellular nucleic acids | |
| US20110244461A1 (en) | Method for preparing stool sample, solution for preparing stool sample and stool collection kit | |
| CN105176969B (en) | A kind of method for extracting nucleic acid and reagent for biological sample | |
| CN106591473B (en) | A kind of people MTHFR and MTRR genetic polymorphism detections primer, probe, kit and method | |
| CN105039538B (en) | A kind of reaction solution and its kit for the direct fluorescent PCR amplification of blood | |
| US20080206866A1 (en) | Reagency and Method for Preventing Time-Dependent Expression in Biological Cells | |
| CN105506129A (en) | RNA type sample preservation and dilution liquid and preparation thereof | |
| CN104032038B (en) | Detection kit and detection method for siniperca chuatsi rhabdoviruses | |
| CN109337899A (en) | A kind of nucleic acid extraction and PCR detection kit | |
| CN111518821A (en) | Mycoplasma bovis growth essential protein CDNPase under cell co-culture | |
| KR20220164716A (en) | Rapid detection of viral infection using RT-PCR | |
| US20110256584A1 (en) | Culture medium for cultivation and identification of bacteria of genus pectinatus and method for taking swab samples | |
| CN109593756A (en) | A kind of extracting solution and its application in preservation tissue or cell, extraction RNA | |
| CN112280823A (en) | Novel coronavirus RNA sample preservation solution, preparation method and application thereof | |
| CA3123402A1 (en) | Matrices and methods for storage and stabilization of biological samples comprising viral rna | |
| CN113930418B (en) | Nucleic acid releasing agent and nucleic acid releasing method thereof | |
| CN109609499A (en) | A kind of extracting solution and its application in extraction RNA | |
| JP2018166410A (en) | Methods for long term storage of nucleic acid in biological samples | |
| JP6733951B2 (en) | Nucleic acid storage composition and nucleic acid storage method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |